O'Keefe, Barry R <br/><br/>
Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Apr 2009 
 - 6099-104 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1091-6490 
<br/><br/><label>Standard No.: </label>10.1073/pnas.0901506106  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Algal Proteins--genetics<br/>Animals<br/>Cell Proliferation--drug effects<br/>Cells, Cultured<br/>Cervix Uteri--surgery<br/>Cytokines--biosynthesis<br/>Drug Evaluation, Preclinical<br/>Female<br/>HIV Envelope Protein gp120--metabolism<br/>HIV Fusion Inhibitors--adverse effects<br/>HIV Infections--prevention & control<br/>HIV-1--drug effects<br/>Humans<br/>Lectins--genetics<br/>Plant Lectins<br/>Protein Binding<br/>Rabbits<br/>Tissue Culture Techniques<br/>Tissue Transplantation<br/>Nicotiana--genetics